Funding Rounds
Coave Therapeutics

Coave Therapeutics Series B (2017, $20M)

Coave Therapeutics

Gene therapies for rare diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $20.90M

Raised Date: 2017-08-01

Investors